Clinical Genetics and Pregnancy Flashcards

(33 cards)

1
Q

When may a clinical geneticist be required during a pregnancy?

A

If there is an FH of disease that may affect the pregnancy, either the foetus or mother

If there is an unexpected finding in pregnancy:
• Genetic testing
• USS

If a previous pregnancy / child has malformations

If a test report needs to be clarified or further understood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How to genetically test a baby in utero?

A

Required foetal DNA:
• From the placenta - Chorionic Villus Biopsy/Sampling (CVS)
• Skin / urine cells - amniocentesis
• Blood - foetal blood sampling

Can also acquire foetal DNA from maternal serum, with non-invasive prenatal testing (NIPT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When is CVS done?

A

Usually at ~11.5 weeks; it should be done <12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Issues assoc. with CVS?

A

Miscarriage risk of 1-2%

Tissue viability is good

There is a risk of CONFINED PLACENTAL MOSAICISM (discrepancy between the genetic makeup of the baby and placenta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When is amniocentesis done?

A

16 weeks +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Issues assoc. with amniocentesis?

A

Miscarriage risk of 0.5-1%

Tissue viability is poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When is foetal blood sampling done?

A

Not commonly used but, when used, it is at 18 weeks +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Issues assoc. with foetal blood sampling?

A

Miscarriage risk of 1-2%

Tissue viability is good

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is foetal DNA from maternal blood (NIPT) used?

A

8 weeks +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Issues assoc. with NIPT?

A

No risk of miscarriage

Tissue viability is stable

However, only limited analyses is currently available and not all chromosomes can be checked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Analyses methods that are available?

A
For the whole genomes:
• Standard karyotype (in metaphase)
• Array CGH (aCGH) 
• Quantification of foetal DNA in maternal serum 
• Whole genome sequencing 

Targeting:
• Point mutation testing
• Fluorescence In-Situ Hybridisation (FISH) - not used unless for demonstration purposes; it is useful when the missing piece of chromosome is too small to see
• Quantitative Fluorescent PCR (QF-PCR) - used to rapidly count the chromosomes, e.g: from amniocentesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can aCGH detect?

A

Chromosomal imbalances (NOT BALANCED TRANSLOCATIONS)

Extra chromosomal material

Missing chromosomal material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Define a mutation?

A

Genetic change that causes disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Define a polymorphism?

A

Genetic variation that is not disease-causing per se

Includes:
• Single Nucleotide Polymorphisms (SNP) - single base changes
• Copy Number Variations (CNV) - insertions or deletions of DNA segments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Differences between mutations and polymorphisms?

A

Mutations tend to be:
• De-novo, i.e: arising in the child and not present in either parent
• Bigger
• Affect a known gene
• Previously reported in the same phenotype

Polymorphisms tend to:
• Normal parent has it
• Smallar
• Affecting an 'empty' genetic region
• Previously reported as a polymorphism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Purpose of QF-PCR?

A

Rapid counting of specific chromosomes

17
Q

When is aCGH of chromosome analysis used?

A

High risk of chromosomal trisomy on screening

Fetal abnormality on scanning:
• Small size, esp. if symmetrical growth failure
• Increased nuchal thickness (NT)
• Structural malformation, e.g: of brain or heart

Parent has balanced chromosomal rearrangement

18
Q

Methods of prenatal screening in Scotland?

A

Dating USS, with serum biochemistry (~12 weeks):
• Increased NT may be seen (suggestive of Down’s syndrome)

Serum screening at ~16 weeks:
• Maternal blood test to look for biochemical markers of Down’s syndrome

20 week detailed scan (AKA foetal anomaly scan):
• Look for other fetal abnormalities

19
Q

What is NIPT currently used for?

A

Sex determination and trisomy testing

It is also occasionally used to check for chromosome deletions or for single genes

20
Q

Why is NIPT more difficult that it seems?

A

Only 10% of the DNA comes from the foetus; the rest is maternal

21
Q

What should be done in the following situation?

Mrs Pink, who is 10 weeks pregnant, comes to see you. She has a son who is affected with DMD.

A

Use NIPT for foetal sexing:
• If female, reassure the patient, as females are unaffected by DMD
• If male, do CVS to check whether DMD is present

NOTE - medically, foetal sexing is useful to check for X-linked conditions

22
Q

What should be done in the following situation?

Mrs Green is 12 weeks pregnant; her serum biochemistry and NT measurement give a risk of 1/40 that the baby is affected with Down’s syndrome.

23
Q

What should be done in the following situation?

Mrs Blue, who is 18 weeks pregnant, comes to see you. A detailed scan has shown that her baby has an AV septal defect, commonly seen in Down’s syndrome.

A

Do amniocentesis, as she is 15 weeks +, and use aCGH

NIPT is not the best option here, as that looks for specific chromosomes, not all of them; an AV septal defect can be caused by numerous genetic disorders, so all the chromosomes must be checked
NOTE - in this case, the cause was DiGeorge syndrome

Also, aCGH detects small deletions, e.g: 22q11 deletion

Following this, the patient can decide on TOP

24
Q

Types of chromosomal changes that can cause disease?

A

Aneuploidy:
• Extra chromosomes
• Fewer chromosomes

Rearrangements inc:
• Translocations
• Inversions

Deletions or duplications

25
Types of translocations?
Robertsonian - 2 acrocentric chromomosomes stuck end-to-end, leading to an increased risk of trisomy in pregnancy Reciprocal - exchange of material between nonhomologous chromosomes These translocations can be either: • Balanced chromosome rearrangement - all the chromosomal material is present • Unbalanced chromosome rearrangement - extra or missing chromosomal material, usually 1 or 3 copies of some of the genome NOTE - having 1 or 3 copies of a part of your genome is developmentally bad news
26
Compare sex chromosome aneuploidy to X-inactivation?
Sex chromosome aneuploidy is better tolerated
27
Potential outcomes of an R(14;21) Robertsonian translocation?
* Normal foetus * Balanced translocation * Trisomy 14 (miscarriage) * Trisomy 21 (Down's syndrome) * Others
28
Does an aCGH reveal balanced translocation?
Normal NOTE - aCGH only detects unbalanced chromosome rearrangement
29
Reproductive risks assoc. with reciprocal translocation?
For most translocations, 50% of conceptions will have either normal chromosomes or balanced translocation Unbalanced products result in: • Miscarriage (large translocations) • Dysmorphic delayed child (small translocations)
30
Why are larger translocations better than small translocations?
Generally, larger translocations are more likely to cause miscarriage; however, if the pregnancy continues, it will usually be completely normal Smaller translocations are more viable but tend to result in severe phenotypes
31
Why is it useful to have an antenatal test, despite having no places for TOP?
Can influence decision for TOP Helps with plans and management
32
What should be done in the following situation? Mrs Roberts, who is 10 weeks pregnant, comes to see you. She has a balanced reciprocal translocation between chromosome 4 and chromosome 9, that has a high risk of causing a liveborn child with multiple malformations.
Chorionic villus biopsy (as she is <12 weeks)
33
Rules for TOP?
Surgical termination should occur <13 weeks; induction occurs thereafter No time limit on TOP if: • Risk of serious abnormality in the child • Risk to the health of the mother